RIVVE & MC Pharma
Press Release - Jan 2026
RIVVE Life Science Strengthens GCC Portfolio and Expands Regional Presence with MC Pharma
RIVVE Life Science, a GCC-focused pharmaceutical commercialization partner, today announced a strategic alliance with MC Pharma , aimed at strengthening its product portfolio for commercialization across the Gulf Cooperation Council (GCC).
Under the agreement, RIVVE will in-license and commercialize a selection of regional and international pharmaceutical brands from MC Pharma’s portfolio across key GCC markets, including the UAE and Saudi Arabia. This partnership enhances RIVVE’s ability to bring high-quality, innovative therapies to the region while accelerating market access for its partners.
MC Pharma holds a diverse portfolio of regional and international brands, positioning it as a strong partner for expanding product availability across the GCC. The alliance also provides RIVVE with a strategic presence in North Africa, leveraging MC Pharma’s local capabilities and market expertise.
“Following our successful expansion across the GCC, this partnership reflects a strong opportunity aligned with increasing demand from our global partners,” said Mostafa Nagib, Chief Executive Officer of RIVVE Life Science. “By in-licensing products from MC Pharma, we are further strengthening our GCC portfolio while ensuring efficient, compliant commercialization across the region.”
“This collaboration enables us to introduce a broader range of high-value products into the GCC, addressing unmet medical needs and supporting healthcare system priorities,” said Rana Osama, Business Development Executive at RIVVE Life Science. “At the same time, it establishes a strong foundation for our continued expansion into North Africa through a trusted local partner.”
RIVVE Life Science operates within a broader regional ecosystem alongside established commercialization companies. Through its differentiated and agile model, RIVVE continues to deliver tailored solutions that enable partners to scale efficiently across high-growth markets.
About RIVVE Life Science
RIVVE Life Science is a GCC-focused pharmaceutical commercialization partner, providing integrated, end-to-end services across regulatory strategy, market access, and commercial execution. The company’s mission is to enable biopharmaceutical organizations to successfully establish, expand, and sustain their presence across the UAE, Saudi Arabia, and the wider Middle East.